We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

26 hedge funds and large institutions have $8.05M invested in TriSalus Life Sciences Warrant in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more capital invested

Capital invested by funds: $5.36M → $8.05M (+$2.68M)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

13% less funds holding

Funds holding: 30 → 26 (-4)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
10
Calls
$933K
Puts
–
Net Calls
+$933K
Net Calls Change
+$175K

Top Buyers

1
MF
Magnetar Financial
Illinois
+$288K
2
MP
Mangrove Partners
Connecticut
+$215K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
+$73.7K
4
IM
Islet Management
New York
+$70.5K
5
MP
MSD Partners
New York
+$57.3K

Top Sellers

1
BlackRock
BlackRock
New York
-$473K
2
PWAM
Park West Asset Management
California
-$217K
3
AC
Aristeia Capital
Connecticut
-$205K
4
GL
Governors Lane
New York
-$133K
5
LA
Linden Advisors
New York
-$132K
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$4.9M +$215K +500,000 New
RCM
2
Radcliffe Capital Management
Pennsylvania
$1.35M – – –
AGC
3
Angelo Gordon & Co
New York
$939K – – –
MF
4
Magnetar Financial
Illinois
$315K +$288K +668,921 +116%
DM
5
Deerfield Management
New York
$85K – – –
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$44K +$73.7K +171,370 New
SCC
7
Spring Creek Capital
Kansas
$42K – – –
IM
8
Islet Management
New York
$42K +$70.5K +163,979 New
VI
9
Vestcor Inc
New Brunswick, Canada
$38K – – –
KC
10
Kepos Capital
New York
$37K – – –
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$34K – – –
MP
12
MSD Partners
New York
$34K +$57.3K +133,333 New
Walleye Capital
13
Walleye Capital
New York
$27K +$210 +488 +0.5%
BCL
14
Bracebridge Capital LLC
Massachusetts
$25K +$42.5K +98,857 New
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
$24K – – –
SCM
16
Shaolin Capital Management
Florida
$20K – – –
CCM
17
Context Capital Management
California
$18K – – –
AA
18
AQR Arbitrage
Connecticut
$17K – – –
QGA
19
Q Global Advisors
Texas
$13K -$9.61K -22,349 -31%
BCM
20
Basso Capital Management
Connecticut
$13K +$22.6K +52,468 New
MA
21
MYDA Advisors
New York
$11K -$33K -76,851 -64%
Jane Street
22
Jane Street
New York
$4K +$7 +17 +0.1%
Nomura Holdings
23
Nomura Holdings
Japan
$3K – – –
OCAM
24
Owl Creek Asset Management
New York
$3K – – –
HF
25
HRT Financial
New York
$3K +$1.16K +2,700 +21%
1
2

TLSIW Hedge Fund Activity: Q1 2022 in Review

26 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2022, worth a combined $8.05M — up 50% from $5.36M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TLSIW and 6 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was Magnetar Financial, adding an estimated $288K. The largest seller was BlackRock, exiting entirely with an estimated $473K sold.

  • 26 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2022, down from 30 in Q4 2021.
  • Funds reported $8.05M of TriSalus Life Sciences Warrant stock for Q1 2022, up 50% quarter-over-quarter.
  • 6 funds opened new TriSalus Life Sciences Warrant positions in Q1 2022 and 10 closed out, a net change of -4 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q1 2022 was Magnetar Financial, an estimated $288K added.
  • The largest TriSalus Life Sciences Warrant seller in Q1 2022 was BlackRock, an estimated $473K sold.

Based on aggregated 13F filings for Q1 2022.